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associated with exposure to perfluorinated
alkylates
Ulla B. Mogensen1, Philippe Grandjean2,3*, Carsten Heilmann4, Flemming Nielsen3, Pál Weihe5
and Esben Budtz-Jørgensen1Abstract
Background: Exposure to perfluorinated alkylate substances (PFASs) is associated with immune suppression in
animal models, and serum concentrations of specific antibodies against certain childhood vaccines tend to
decrease at higher exposures. As such, we investigated the immunotoxic impacts of the three major PFASs in a
Faroese birth cohort.
Methods: A total of 464 children contributed blood samples collected at age 7 years. PFAS concentrations and
concentrations of antibodies against diphtheria and tetanus were assessed in serum at age 7 years, and results
were available from samples collected at age 5. In addition to standard regressions, structural equation models
were generated to determine the association between three major PFASs measured at the two points in time
and the two antibody concentrations.
Results: Concentrations of all three 7-year PFAS concentrations were individually associated with a decrease in
concentrations of antibodies, however, it was not possible to attribute causality to any single PFAS concentration.
Hence, the three 7-year concentrations were combined and showed that a 2-fold increase in PFAS was associated
with a decrease by 54.4 % (95 % CI: 22.0 %, 73.3 %) in the antibody concentration. If considering both the age-5
and age-7 concentrations of the three major PFASs, the exposure showed a slightly greater loss.
Conclusions: These analyses strengthen the evidence of human PFAS immunotoxicity at current exposure levels
and reflect the usefulness of structural equation models to adjust for imprecision in the exposure variables.Background
Perfluorinated alkylate substances (PFASs) are applied in
water-, soil-, and stain-resistant coatings for clothing and
other textiles, oil-resistant coatings for food wrapping ma-
terials, and other products. Hence, human PFAS expo-
sures may therefore originate from PFAS-containing
products or from environmental dissemination, including
house dust, ground water, and seafood [1, 2]. Although
systematic toxicity testing has not been carried out, animal
models have suggested that immunotoxicity may be an
important outcome of PFAS exposures at levels commonly* Correspondence: pgrand@hsph.harvard.edu
2Department of Environmental Health, Harvard School of Public Health, 401
Park Drive, 3E110, Boston, MA 02215, USA
3Department of Environmental Medicine, University of Southern Denmark,
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© 2015 Mogensen et al. This is an Open Acce
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any medium, provided the original work is p
(http://creativecommons.org/publicdomain/zeroencountered [3]. Pursuant to the above, in the mouse,
exposure to perfluorooctane sulfonic acid (PFOS) caused
a variety of immunotoxic consequences, including de-
creased immunoglobulin response to a standard antigen
challenge [4, 5]. These associations were reported at
serum concentrations similar to, or somewhat higher, than
those widely occurring in humans.
In human studies, childhood vaccination responses can
be applied as feasible and clinically relevant outcomes, as
the children have received the same antigen doses at simi-
lar ages [6]. Using this approach, a birth cohort established
in the Faroe Islands showed strong negative correlations
between serum PFAS concentrations at age 5 years and
antibody concentrations before and after booster vaccin-
ation at age 5, and 2.5 years later [7]. However, the expos-
ure assessment relied on a single serum sample obtained
at age 5. Serial analyses of serum samples from formerss article distributed under the terms of the Creative Commons Attribution
s/by/4.0), which permits unrestricted use, distribution, and reproduction in
roperly credited. The Creative Commons Public Domain Dedication waiver
/1.0/) applies to the data made available in this article, unless otherwise stated.
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half-lives of ~3 years for perfluorooctanoic acid (PFOA)
and ~5 years for perfluorooctanesulfonic acid (PFOS) [8],
and declines in serum-PFOA concentrations in an exposed
community after elimination of the water contamination
suggested a median elimination half-life of 2.3 years [9]. Al-
though serum-PFAS concentrations in adults may be fairly
stable over time, substantial age-dependent changes occur
during childhood [10]. In addition, uncertainty prevails
about the relevant exposure window in regard to possible
adverse effects in children. Further, binding to serum
albumin [11] and body mass index [12] may affect
serum concentrations of these substances. Accordingly,
imprecision of serum concentrations as exposure indi-
cators must be taken into regard in the data analysis.
Serum-PFAS concentrations of the Faroese birth co-
hort at age 7 have now been determined, and possible
confounders have been ascertained. We can therefore
link the immunotoxic outcomes to prospective expos-
ure data. As before [7], we focus on the three major
PFASs, i.e., PFOA, PFOS, and perfluorohexanesulfonic
acid (PFHxS). Given the fact that three substances were
measured postnatally on two occasions and that two dif-
ferent antibody concentrations are available as outcome
variables, we complemented standard regression analysis
with structural equation models. These models are power-
ful tools to simultaneously study the associations of sev-
eral correlated exposures with several outcomes while
taking into account exposure uncertainty, missing data,
and covariates [13, 14].
Methods
Study population
A cohort of 656 children was compiled from births at
the National Hospital in Tórshavn in the Faroe Islands
during 1997–2000 to explore childhood immune func-
tion and the impact on vaccination efficacy [7]. Faroese
children receive vaccinations against diphtheria, tetanus,
and other major antigens at ages 3 months, 5 months,
and 12 months, with a booster at 5 years, as part of the
government-supported health care system. All children
received the same amount of vaccines and associated
alum adjuvant from the same source, although add-
itional vaccines (pertussis and polio) were added to the
booster during the project period. Of the 464 children
participating in the age-7 examination, 412 had previ-
ously undergone the 5-year testing in connection with
the booster vaccination. Six children were excluded, as
they had more recently received an additional booster
vaccination. The study protocol was approved by the
Faroese ethical review committee and by the institu-
tional review board at the Harvard School of Public
Health; written informed consent was obtained from all
mothers.The PFAS concentrations were measured in serum at
age 5 (before the booster vaccination) and age 7. As albu-
min is likely a major binding protein [11], the serum-
albumin concentration was analyzed in all age-7 serum
samples to allow adjustment for this possible source of
variability. PFAS concentrations were measured by online
solid-phase extraction and analysis using high-pressure li-
quid chromatography with tandem mass spectrometry [7].
Within-batch and between-batch imprecision (assessed by
the coefficient of variation) were better than 5.6 % for all
analytes. Results with excellent accuracy were obtained in
the regular comparisons organized by the German Society
of Occupational Medicine.
Serum concentrations of antibodies were measured by
the vaccine producer (Statens Serum Institut, Copenhagen,
Denmark) using enzyme-linked immunosorbent assay for
tetanus and, for diphtheria, a Vero cell-based neutralization
assay using 2-fold dilutions of the serum. For both assays,
calibration was performed using both international and
local standard antitoxins.
Statistical methods
Antibody concentrations and PFAS exposures were all
log-transformed (base 2) before they entered the models.
Initial analyses were based on separate multiple linear re-
gressions with an antibody concentration as the dependent
variable and a serum-PFAS concentration as a predictor
along with age, sex, and booster type. The assumptions of
linear dose–response associations were verified by allow-
ing for a more flexible relation between the PFAS and the
antibody concentration in generalized additive models
using cubic regression splines with three knots [15].
Structural equation models (SEMs) allow for a joint
analysis of multiple exposures with several outcome vari-
ables [14, 16]. SEMs typically consists of a measurement
model in which the observed variables are linked to a
limited number of latent variables and a structural
model describing the relationship between the latent
variables with possible adjustment for the effects of co-
variates. We considered models with an increasing
complexity where the measurement models included
an increasing proportion of the available variables from
the longitudinal multivariate exposure profile of the
subjects.
Model 1 included both the 5-year and 7-year concen-
trations of the same PFAS as shown in Fig. 1 for PFOA
exposure and its association with the anti-diphtheria
antibody concentration (other PFASs and associations
with anti-tetanus were modeled similarly). We considered
the two observed PFOA concentrations at ages 5 and
7 years: (log PFOA5, log PFOA7) as proxy variables for
the latent true long-term exposure level (logPFOA):
logPFOA5 ¼ logPFOAþ ε5 ð1Þ
Fig. 1 Structural equation model for the association between the latent PFAS concentration and the antibody concentration adjusted for
covariates (Additional file 1: Model 1). The model is shown for the relation between latent PFOA (circle) measured by the 5- and 7-year observed
concentrations (left squares) and anti-diphtheria (right square). “Covariates” (middle square) are age, sex, and booster type that predicts the latent
variable and the two antibody concentrations additively and linearly
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Thus, after a log-transformation the observed concen-
tration is a sum of the truth and random measurement
error. The parameter α allows for a general change in
the concentration level from age 5 to 7. We further as-
sumed the latent PFOA concentration affect the anti-
diphtheria concentration linearly after adjustment for
covariates (denoted C1,…, Ck):
log Anti‐diphtheria7 ¼ β0 þ β1 • logPFOA
þ β2 • C1 þ ⋯ þ βkþ1 • Ck þ ε:
ð3Þ
The regression coefficients have the same interpreta-
tions as in standard regression analyses, but this model
include adjustment for measurement errors, as it is the
underlying latent variable, and not the observed expos-
ure which are assumed to affect the outcome. In
addition, we allowed for correlations between covariates
and exposure variables by assuming that the covariates
affected the latent variable (see Additional file 1, p. 3).
The model was extended to allow for the possible de-
pendence for observed PFAS concentrations on the
serum-albumin concentration. This was done by modify-
ing the equations (1) and (2) such that the observed PFOA
concentrations depended on albumin in addition to the
latent PFOA exposure level (see Additional file 1, p. 5).
Note that because we modeled the influence of albumin
on the observed concentrations, the model allows children
with the same underlying exposure to have different mea-
sured PFOA concentrations. A similar approach was used
for body mass index (body weight divided by the squared
height).
To compare the effects of the different PFASs, we
combined the individual PFAS models into a single
SEM (Additional file 1: Model 2) that allowed antibody
concentrations to depend on all three latent PFAS con-
centrations (see Additional file 1, p. 5–6).We then considered models where concentrations of
the three major PFASs were viewed as reflections of a la-
tent variable representing the overall true PFAS expos-
ure concentration. We first developed a measurement
model for 7-year concentrations (logPFOA7, logPFOS7,
logPFHxS7)
log PFOA7 ¼ α1 þ λ1 • logPFAS þ ε1 ð5Þ
log PFOS7 ¼ α2 þ λ2 • logPFASþ ε2 ð6Þ
log PFHxS7 ¼ α3 þ λ3 • logPFAS þ ε3; ð7Þ
where logPFAS represent the joint latent PFAS con-
centration and ε1, ε2, ε3 are measurement errors. The
latent PFAS variable was then related to the antibody
concentrations as in equation (3) (see Additional file 1:
Figure S3). This model is similar to the 5-year PFAS
exposure model previously used [7].
To investigate if the PFAS exposure at age 5 or 7 years
had the strongest effect on antibody concentrations, we
included a similar model for the latent 5-year PFAS ex-
posure and allowed antibody concentrations to depend
on the latent PFAS variables at both age 5 and age 7;
Additional file 1: Model 4 (see Additional file 1, p. 9–10).
As a final model (Additional file 1: Model 5), we ex-
tended the joint latent PFAS exposure reflect both sets of
serum concentrations at 5 and 7 years, the latter entering
the measurement model for the latent PFAS exposure with
equations similar to equations 5–7, thus leading to a total
of six equations (see full details in Additional file 1, p. 12).
We allowed for the possibility that the three concentrations
obtained at the same exposure age were correlated (locally
dependent) even after conditioning on the latent variable
(Fig. 2). This association was assumed to be equally
strong for the two exposure assessments. Furthermore,
we modeled a local dependence between the age 5 and
7 concentrations for each PFAS. As in the previous
models, the latent PFAS variable was then related to
the antibody concentrations after adjustment for covariates.
Fig. 2 Structural equation model for latent PFAS exposure (middle circle) manifested by concentrations of PFOA, PFOS, and PFHxS at year 5 and
7 (left squares); Additional file 1: Model 5. The dashed (doubled-headed) arrows indicate the local dependencies between the manifest variables.
Local dependence between concentrations at the same age is modeled by latent variables Year 5 and Year 7 (left circles). “Covariates” (middle square)
are age, sex, and booster type that predicts the joint latent PFAS variable and the two antibody concentrations additively and linearly
Table 1 Characteristics of children that contributed with a 7-year
antibody determination
Variable Summary
Children (n = 459)
Girls, No. (%) 222 (48.4 %)
Booster vaccine (n = 448)
Booster vaccine type 1, No. (%) 147 (32.8 %)
Serum albumin concentration, median (IQRa), g/L
At age 5 year (n = 413) 40.3 (38.8, 42.1)
At age 7 year (n = 370) 42.7 (41.2, 44.7)
Antibody concentration at age 7 examination (n = 459)
Age, mean (sd) 7.5 (0.1)
Diphtheria, median (IQR), (IU/mL) 0.8 (0.4,1.6)
Tetanus, median (IQR), (IU/mL) 1.8 (0.6, 4.5)
aIQR Inter quartile range
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analyze incomplete data through a full-information max-
imum likelihood (FIML) procedure [16]. We used this
option in all the SEMs under the assumption that the
data were missing at random [17]. The goodness-of-fit
of the models were assessed with the χ2-test, and the
root mean squared error of approximation (RMSEA).
The χ2-test compares the covariance matrix of the ob-
served variables to the covariance matrix predicted from
the model. The RMSEA measures the lack-of-fit per de-
gree of freedom. In addition, we report the Bentler Com-
parative Fit Index (CFI), and the standardized root mean
square residuals (SRMR) [16]. Models were considered to
have a good fit if the χ2-test yielded a p-value above 5 %,
the RMSEA was below 5 %, CFI was above 0.95 and
SRMR below 0.08 [16]. All analyses were performed using
the statistical software R [18] with the lava package [19].
Results
The characteristics of the children who provided serum
for antibody measurements at age 7 years are shown in
Table 1. PFOS was by far the most prevalent PFAS with
a median serum concentration at age 7 of 15.5 ng/mL
(interquartile range (IQR): 12.9, 19.2 ng/mL) which rep-
resented a decrease from age 5 (Table 2). Notably, the
correlation between the age 5 and age 7 concentrations
of the same PFAS was closer than the correlation between
the different PFASs at each age.
Multiple linear regressions showed that higher 7-year
PFAS concentrations were associated with lower antibody
concentrations. This tendency was most pronounced for
anti-diphtheria that decreased by 30.3 % (95 % CI: 7.8 %,
47.3 %), and 25.4 % (95 % CI: 5.8 %, 40.9 %), for a doubling
in the PFOS and PFOA concentration, respectively(Table 3). For the anti-tetanus antibody, PFHxS showed
the strongest association with a decrease by 22.3 % (95 %
CI: 5.2 %, 36.3 %), for a doubling in the exposure. The
dose–response relations obtained with generalized additive
models verified approximate linearity (Fig. 3).
In the linear regressions we adjusted for gender, age,
and booster type. There were significant differences in
antibody concentrations between genders where girls
had between 23.2 % (95 % CI: 3.8 %, 43.6 %) and 27.2 %
(95 % CI: 4.9 %, 44.2 %) lower concentrations. Children
that received booster type 1 showed slightly higher anti-
body concentrations; however, this tendency was only
borderline significant for anti-diphtheria.
In structural equation models of individual PFASs
(Additional file 1: Model 1; Fig. 1), we focused on the re-
lation of the latent PFAS childhood exposure with the
Table 2 Pearson correlations for the 5- and 7 year PFAS
concentrations. Shown are also the median (IQR) PFAS
concentrations
Pairwise correlation at age 7 year
Compound PFAS concentration,
ng/mL, median (IQRa)
PFOS PFOA PFHxS
Age 5 year
PFOS 17.3 (14.2,21.3) 0.77 0.06 0.43
PFOA 4.1 (3.3, 5.0) 0.34 0.61 0.39
PFHxS 0.6 (5.0, 0.9) 0.40 0.27 0.85
Age 7 year
PFOS 15.5 (12.8, 19.2) 1
PFOA 4.4 (3.5, 5.7) 0.29 1
PFHxS 0.5 (0.4,0.7) 0.50 0.34 1
aIQR Inter quartile range
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concentration was positively associated with the observed
PFAS measurements, albumin adjustment affected the
association of the estimated exposure only to a negli-
gible extent (Table 3 shows the unadjusted estimates,
Additional file 1: Table S1 shows the albumin-adjusted esti-
mates). Similarly, we also considered adjustment for BMI,
but again with virtually no impact on the results. Conse-
quently, these adjustments were not further considered.
The three latent PFAS variables showed a trend of in-
verse relationships with each of the antibody concentra-
tions. The effects of PFOS and PFOA were strengthened
in comparison to the regression coefficients based on in-
dividual 7-year concentrations only. In particular the
anti-tetanus concentration showed a decrease of 38.2 %
(95 % CI: 13.0 %, 56.1 %), for a doubling in the average
childhood PFOA concentration (Table 3, AdditionalTable 3 The percentage change (% Change) in antibody concentra
Results are from multiple linear regressions for PFAS concentrations
models of latent individual PFAS measured by 5- and 7-year conce
equation model with all three latent PFASs (1 model shown in row
age, and booster type
PFOS
Antibody N % Change
Linear regression:
Anti-diphtheria 443 −30.3
Anti-tetanus 443 −9.1
SEMa (Additional file 1: Model 1)
Anti-diphtheria 448 −34.3
Anti-tetanus 448 −16.3
SEM mutually adjustedb, Additional file 1: Model 2
Anti-diphtheria 448 −26.1
Anti-tetanus 448 18.7
aSee Fig. 1. Goodness of fits: χ2-test P: 0.08–0.88, RMSEA: ≤ 0.01–0.06, CFI: 0.99–1.00
bSee Additional file 1: Figure S2. Goodness of fits: χ2-test P: ≤ 0.01, RMSEA: 0.06, CFIfile 1: Model 1). This decrease was nearly twice the
magnitude of the decrease obtained in the linear re-
gressions that ignore measurement errors. When the
three latent PFASs were mutually adjusted the associa-
tions became less apparent and only anti-tetanus anti-
body showed a borderline significant decrease by 29.6 %
(95 % CI: −0.4 %, 50.6 %) at a doubling of PFOA exposure
after this adjustment (Table 3, Additional file 1: Model 2).
As expected the precision of the coefficients decreased.
As it was not possible to attribute causality to individ-
ual PFAS compounds, we combined the data for all
three substances at age 7 in a joint latent exposure vari-
able. This total PFAS exposure variable showed the
strongest association with anti-diphtheria, which was re-
duced by more than one half (57.5 %; 95 % CI: 21.2 %,
77.0 %) for a doubling of the PFAS concentration
(Table 4, Additional file 1: Model 3). The anti-tetanus
concentration similarly showed a decrease by 49.8 %
(95 % CI: 2.7 %, 74.1 %), for a doubling in the PFAS
concentration.
The PFAS associations with the two antibody concentra-
tions were similar and could be assumed to be identical
(P = 0.64). The estimated joint change in antibody concen-
tration then showed a decrease by 54.4 % (95 % CI: 22.0 %,
73.3 %), per doubling of the latent age-7 PFAS exposure.
The impacts of the 5-year PFAS exposure were dramat-
ically reduced when adjusted for the 7-year PFAS exposure
(Additional file 1: Model 4, Additional file 1: Table S2).
Likewise, the estimated decrease in the antibody concen-
tration per doubling in the 7-year concentration was
halved after adjustment of the 5-year concentration. At
the same time, the precision of the coefficients decreased,
with much wider confidence intervals. As the data did not
allow separation of influences attributed to 5-year ortion at age 7 years when the PFAS concentration is doubled.
at age 7 years (6 models shown in row 1–2), structural equations
ntrations (6 models shown in row 3–4), and one structural
5–6). All models were adjusted for the covariates gender,
PFOA PFHxS
95 % CI % Change 95 % CI % Change 95 % CI
−47.3, −7.8 −25.4 −40.9, −5.8 −16.7 −30.8, 0.2
−32.8, 23.0 −20.5 −38.2, 2.1 −22.3 −36.3, −5.2
−52.8, −8.9 −34.7 −52.5, −10.2 −13.9 −27.9, 2.7
−41.5, 19.3 −38.2 −56.1, −13.0 −18.7 −32.8, −1.7
−49.4, 7.9 −26.9 −47.4, 1.5 1.7 −17.7, 25.8
−21.2, 78.7 −29.6 −50.6, 0.4 −15.0 −32.4, 6.8
, SRMR: 0.01–0.02
: 0.99, SRMR: 0.03
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Fig. 3 Associations between PFAS and antibody concentrations at age 7 years. Dose–response functions are modeled by generalized additive
models with cubic smoothing spline with 3 degrees of freedom, adjusted for age, sex, and booster vaccination type. The dashed lines indicate
the 95 % confidence intervals. The spikes on the horizontal line indicate individual observations
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7-year PFAS concentrations into one joint childhood
PFAS exposure (Additional file 1: Model 5; Fig. 2). In
this model, the adverse impact of PFAS increased, and
the precision of the estimates improved. For a doubling
of the PFAS exposure, the antibody concentrations de-
creased by 55.5 % (95 % CI: 25.5 %, 73.4 %).
All analyses were repeated with adjustment also for
the pre-booster antibody concentration at age 5 (see
Additional file 1, p. 13–15). In this analysis, we modeled
the PFAS association with the change in antibody level
from age 5 (pre-booster) to age 7 years. For the multiple
linear regressions, the precision of all estimatesincreased, and the regression coefficients of PFOA, and
PFOS on anti-tetanus and the regression coefficients of
PFOA, and PFHxS on anti-diphtheria were strengthened
(Additional file 1: Table S3). For the SEM of latent individ-
ual PFASs (Additional file 1: Model 1, Additional file 1:
Figure S5), the precision decreased, and estimates were
therefore less stable. In the 7-year joint PFAS exposure
models (Additional file 1: Model 3), all adverse relations
increased while the adverse associations with the joint 5-
year PFAS exposure decreased (Additional file 1: Model 3,
Additional file 1: Table S4). In the final pre-booster
adjusted model (Additional file 1: Model 5), the con-
centration of antibodies decreased by 51.8 % (95 % CI:
Table 4 Structural equation models for the association between antibodies and latent joint PFAS concentrations. Shown are models
for latent PFAS at age 5 years (row 1), latent PFAS at age 7 years (row 2), and latent childhood PFAS (row 3). % Change indicates the
percentages change in antibody concentration for a 2-fold PFAS concentration. All models were adjusted for the covariates gender,
age, and booster type
Diphtheria Tetanus Joint
Model N % Change 95 % CI % Change 95 % CI Pa % Change 95 % CI
Additional file 1: Model 3
PFAS at age 5b 448 −44.8 −65.8, −11.0 −55.9 −73.6, −26.2 0.40 −50.0 −67.2, 23.8
PFAS at age 7c 448 −57.5 −77.1, −21.2 −49.8 −74.1, −2.8 0.64 −54.4 −73.3, −22.0
Additional file 1: Model 5d
PFAS childhood 448 −57.5 −76.9, −21.8 −60.1 −79.3, −22.8 0.64 −55.5 −73.4, −25.5
aP-value for the test of same effect on the two antibodies
bGoodness-of-fit (same effect model,): χ2-test P: 0.20, RMSEA: 0.03, CFI: 0.99, SRMR: 0.02
cGoodness-of-fit (same effect model): χ2-test P: 0.41, RMSEA: 0.01, CFI: 0.99, SRMR: 0.02
dGoodness-of-fit (same effect model): χ2-test P: 0.24, RMSEA: 0.02, CFI: 0.99, SRMR: 0.02
Mogensen et al. Environmental Health  (2015) 14:47 Page 7 of 1024.6 %, 68.5 %), for a doubling of the joint childhood
PFAS exposure, i.e., a slightly weaker association as
compared to the unadjusted model.
The SEMs applied generally showed a good fit to the
data with χ2-test P-values above 5 % and RMSEA
below 5 %. The only exception was the model with
mutually adjusted latent PFASs (Additional file 1:
Model 4, Additional file 1: Table S4) which did not satisfy
the strict P-value criterion, but had acceptable values for
the other fit-indices.
Discussion
The focus of the present study was the association be-
tween PFAS exposure and the serum-antibody concen-
tration at age 7. The new measurements of concomitant
serum-PFAS concentrations at age 7 allowed us to
examine the relation to the current PFAS exposures as
well as the joint exposures at ages 5 and 7. These ana-
lyses showed a stronger inverse association than those
obtained with the 5-year PFAS concentration only. How-
ever, when the 5-year and the 7-year joint PFAS exposures
were mutually adjusted, their substantial correlation made
it impossible to distinguish between the influences of each
of the two sets of exposure data in regard to the antibody
levels. Still, the overall childhood exposures, as reflected
by both the age-5 and age-7 PFAS measurements showed
the strongest inverse association between PFAS exposure
and antibody concentrations.
The amount of antigen in the 5-year booster vaccination
was the same for all children. Thus, the 7-year antibody
concentrations could be meaningfully adjusted for the 5-
year pre-booster antibody level to reveal impacts that
could be ascribed to more recent adverse impacts on anti-
body formation. In this analysis, the joint PFAS association
with the anti-tetanus antibody decreased somewhat as
compared to the unadjusted results, while the association
with the diphtheria antibody remained almost unaffected.
This finding suggests that PFASs primarily affect antibodyproduction rather than preceding steps in immune re-
sponses to antigen stimulation. In vitro studies suggest
that such effects are plausible [20].
Although the impacts of PFAS exposure appear substan-
tial, some residual confounding could still be present. As
PFASs in serum are mainly bound to albumin [11], the
serum concentration of the former may be affected by the
amount present of the latter. However, the association be-
tween PFAS exposure and antibody concentrations chan-
ged only negligibly after adjustment for the albumin
concentration. Similarly, as BMI may also affect the serum
concentrations [21], we considered this covariate as a pos-
sible confounder. Again, the adjusted results were almost
unchanged. All reported results are therefore unadjusted
for albumin and BMI.
In addition to the association with the joint PFAS expos-
ure, we explored the individual influences of PFOS, PFOA,
and PFHxS. The results did not reveal any clear tenden-
cies, thus suggesting that none of the individual PFASs
was the primary explanation of the antibody decrease.
Still, PFOA showed a borderline statistically significant as-
sociation after adjustment for the other PFASs. Most ex-
perimental studies focused on PFOS and PFOA [3] and
very little are known about the immunotoxicity of PFHxS.
The mechanisms of action are unclear. While PFOS and
PFOA in humans may only in part act via the same path-
ways [20], it is unknown if PFHxS shares mechanisms of
action with the other PFASs. Thus, whether a joint ana-
lysis of PFAS exposures has a toxicological foundation is
also uncertain. Nonetheless, the fact that the combined
exposure parameter in the SEMs showed a stronger asso-
ciation with the antibody concentrations would seem to
support some degree of additive effects. Further, the stand-
ard regression analyses suggest that each individual PFAS
has immunotoxic impacts of its own.
Structural equation models proved to be very useful in
the analysis of these data with multiple exposures mea-
sured at different time points and a multivariate outcome.
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from many variables can be combined into a joint analysis
which potentially becomes more powerful than standard
regression modeling. In addition, SEMs allow for measure-
ment error in covariates, which is essential for unbiased
effect estimation, especially in models that include corre-
lated independent variables [22]. We considered a number
of different models to describe the association between
the longitudinal multivariate exposure profile and the anti-
body response at age 7 years. These analyses indicated that
the causative dose is a long-term average where all three
PFASs may contribute. Such an analysis would not be
meaningful in standard regression models, as it would re-
quire that all exposure variables were included simultan-
eously as independent variables. The present study
illustrates how to develop SEMs where observed expo-
sures were assumed to be correlated with underlying
causative latent variables. Some models grouped variables
according to chemical type (PFOS, PFOA or PFHxS) while
others combined information from the same year of ex-
posure (5 or 7 years). We believe that all the models are
relevant as they show different aspects of the relationship
between PFAS exposure level and antibody concentration.
The model selection process resulted in a model where all
exposure variables were related to one causative latent
variable. However, this does not mean that we consider
the final model to be superior in general. Thus, had one of
the underlying analyses clearly indicated that a single
chemical concentration or only a single exposure age was
important, it would not have been appropriate to develop
a model combining all variables.
The increased power of SEMs comes from the fact
that all collected variables are exploited but also from
additional assumptions necessary for inclusion of all var-
iables simultaneously. According to a recent critique,
SEMs often make unrealistic assumptions about the re-
lationships between the covariates [23]. This concern is
not relevant to our analysis, which allowed a completely
flexible model for the covariates. However, multiple ex-
posures were included by postulating the existence of
one or more sets of underlying latent variables. Al-
though a reasonable assumption, the existence of such
unobserved variables is difficult to prove, but statistical
fit indices indicated that these models provided a good
approximation to the data distribution. Our findings
therefore suggest that carefully conducted SEM ana-
lyses with a minimal number of weak assumptions pro-
vide an important supplement to standard regression
results, especially when involving imprecise assessment
of multiple exposures.
In support of our findings of PFAS immunotoxicity, a
recent study of 99 Norwegian children at age 3 years
found that the maternal serum PFOA concentrations
were associated with decreased vaccine responses in thechildren, especially toward rubella vaccine, as well as in-
creased frequencies of common cold and gastroenteritis
[24]. However, PFOS and PFOA concentrations in serum
from 1400 pregnant women from the Danish National
Birth Cohort were not associated with the total
hospitalization rate for a variety of infectious diseases in
363 of the children up to an average age of 8 years [25].
In adults, PFOA exposure was associated with lower
serum concentrations of total IgA, IgE (females only),
though not total IgG [26]. Also, elevated serum-PFOA
serum concentrations were associated with a reduced
antibody titer rise after influenza vaccination [27]. Thus,
overall, support is building that PFAS exposure may be
associated with deficient immune functions, although
the clinical implications need to be defined in detail.
Our study is limited to PFAS exposure assessments at
two points during childhood at an interval of about
30 months. While taking into regard the elimination
half-lives of the PFASs of 2–5 years [8, 9], these two
measurements may not fully characterize the childhood
exposure profile that is most relevant to humoral im-
munity functions. The addition of the age-7 serum con-
centrations clearly improved the association between
PFAS exposure and the antibodies, thus suggesting that
the imprecision of the exposure estimate had decreased.
As exposures during childhood are likely to vary [1, 10],
it is possible that serial serum-PFAS analyses would pro-
vide even stronger evidence for PFAS immunotoxicity.
However, distinguishing between exposures at different
ages and between the associations attributed to different
PFASs will require greater variability and lower correl-
ation between the individual exposure parameters.
The 5-year booster vaccination is in principle the last
booster vaccination that a Faroese child receives, and
long-term protection is therefore anticipated. Our pre-
vious results [7] showed that many children at age 7
had antibody concentrations below the level assumed
to provide the desired protection. Thus, while the exact
magnitude of the serum-antibody concentration may
not be clinically important, very low levels will mean
poor or absent protection. Our findings show that
PFAS exposure may inhibit the formation of antibodies
and cause more children to be unprotected despite a
full regimen of vaccinations. While tetanus and diph-
theria may not be a serious hazard in the Faroese and
many other countries, the strongly decreased antibody
concentrations reflect a severe immunological deficit,
one that is much stronger than the one associated with
PCB exposure [28]. As optimal immune system func-
tion is crucial for health; the associations identified
should be regarded as adverse. We recently calculated
benchmark dose levels to estimate the magnitude of ex-
posure limits that would protect against the immuno-
toxicity observed [29]. The results suggested that
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high. The improved adjustment for imprecision of the
exposure assessment in the present study adds support
to the notion that substantially strengthened prevention
of PFAS exposures is indicated.
Conclusions
The vulnerable window of time for the immunotoxic ef-
fects of PFASs is unknown, and exposure assessment must
therefore take into account temporal changes in serum
concentrations. Structural equation models provided a
useful approach to statistical analysis as they take into ac-
count that each PFAS measurement is likely to an impre-
cise indicator of the causative exposure. These models
also allow for a multivariate response, and incorporate in-
complete data. By incorporation of serum concentrations
at two points in time, the results confirmed and extended
findings in standard regression models where antibody
concentrations decreased as a function of PFAS concen-
trations. This tendency was strengthened in the structural
equation models that included both sets of serum concen-
trations. These analyses add further evidence to the notion
that immunotoxicity may occur in humans at the current
exposure levels.
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